×
NeuroPace EBIT 2020-2025 | NPCE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
NeuroPace ebit from 2020 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
NeuroPace EBIT 2020-2025 | NPCE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
NeuroPace ebit from 2020 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$183.5B
Thermo Fisher Scientific (TMO)
$164.2B
Edwards Lifesciences (EW)
$45.8B
Alcon (ALC)
$43.1B
IDEXX Laboratories (IDXX)
$42.9B
DexCom (DXCM)
$32.7B
IQVIA Holdings (IQV)
$28.2B
Mettler-Toledo (MTD)
$25.4B
STERIS (STE)
$22.4B
Waters (WAT)
$21B
SONOVA HOLDING (SONVY)
$17.4B
Hologic (HOLX)
$14.6B
Sysmex ADR (SSMXY)
$10.6B
Penumbra (PEN)
$9.2B
Masimo (MASI)
$8.8B
Globus Medical (GMED)
$7.7B
Glaukos (GKOS)
$5.9B
Teleflex (TFX)
$5.1B
Integer Holdings (ITGR)
$4.2B
TransMedics (TMDX)
$3.8B
PROCEPT BioRobotics (PRCT)
$3.1B
LivaNova (LIVN)
$2.4B
Veracyte (VCYT)
$2.1B
Nihon Kohden (NHNKY)
$1.9B
Elekta AB (EKTAY)
$1.9B
Alphatec Holdings (ATEC)
$1.6B
Artivion (AORT)
$1.3B
Paragon 28 (FNA)
$1.1B
Pulse Biosciences (PLSE)
$1.1B
OPKO Health (OPK)
$1.1B